Trial Profile
A Phase 1, Randomized, Open-label, Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole Lauroxil Following Administration to the Deltoid or Gluteal Muscle in Adults With Schizophrenia or Schizoaffective Disorder
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2016
Price :
$35
*
At a glance
- Drugs Aripiprazole lauroxil (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Alkermes
- 13 Jul 2016 Status changed from active, no longer recruiting to completed.
- 10 May 2016 Status changed from recruiting to active, no longer recruiting.
- 24 Dec 2015 New trial record